DHR Trading Analysis - 09/21/2026 10:31 AM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for DHR include:

• Danaher Corporation (DHR) announced its Q2 2026 earnings on July 23, 2026, with revenue growth of 3.4% YoY.
• On August 12, 2026, DHR completed the acquisition of Sartorius Stedim Biotech, expanding its life sciences portfolio.
• On September 15, 2026, DHR launched its latest innovation in microscopy, further strengthening its position in the life sciences sector.

These headlines suggest a positive trend for DHR, with growth in revenue and expansion in its life sciences portfolio. The recent launch of new products also indicates a strong commitment to innovation.

Fundamental Analysis:

Revenue Growth: The revenue growth rate is not explicitly provided, but we can analyze the trend from the daily history data. The revenue for the trailing twelve months is $24,778,000,000.

Profit Margins: The gross margin is 58.94%, operating margin is 19.21%, and net profit margin is 14.89%. These margins indicate a strong profitability position for DHR.

Earnings Per Share (EPS): The trailing EPS is $5.17. Without the forward EPS, it's challenging to assess the growth prospects directly, but the recent price action and institutional interest suggest a positive outlook.

P/E Ratio and Valuation: The trailing P/E ratio is 40.97. Given the PEG ratio is not provided, we can't directly assess if the stock is undervalued or overvalued compared to its growth rate. However, a P/E of 40.97 suggests a relatively high valuation, which might be justified by the company's strong growth prospects and profitability.

Key Fundamental Strengths or Concerns: The debt-to-equity ratio is 0.35, indicating a manageable level of debt. The return on equity (ROE) is 6.97%, which is relatively healthy. The lack of free cash flow data makes it difficult to assess the company's liquidity position directly.

Current Market Position:

Current Price and Recent Price Action: The current price is $213.15. From the minute bars data, we see that the stock has been trading in a relatively narrow range recently, with a slight upward bias.

Key Support and Resistance Levels: The 50-day SMA is $204.12, and the 20-day SMA is $209.82. These levels can act as support. The recent high is $214.10, which could act as resistance.

Intraday Momentum and Trends: The intraday momentum from the minute bars shows a slight uptrend, with the stock making higher highs and higher lows.

Technical Analysis:

SMA Trends: The 5-day SMA is $211.04, the 20-day SMA is $209.82, and the 50-day SMA is $204.12. The short-term SMAs are above the 50-day SMA, indicating a bullish trend.

RSI: The RSI (14) is 49.46, which is neutral but leaning towards the bullish side as it approaches 50.

MACD: The MACD is 1.32, with a signal line of 1.06 and a histogram of 0.26. This suggests a bullish signal.

Bollinger Bands: The middle band is $209.82, the upper band is $219.74, and the lower band is $199.90. The stock is trading near the middle band, with room to move towards the upper band.

30-day High/Low: The 30-day high is $220.67, and the low is $199.09. The stock is currently near the middle of this range.

True Sentiment Analysis (Delta 40-60 Options):

Overall Options Flow Sentiment: The sentiment is bullish, with a call dollar volume of $8590 and a put dollar volume of $350. The call percentage is 96.1%, indicating strong bullish conviction.

Call vs Put Dollar Volume Analysis: The significant dominance of call buying over put buying suggests that traders are positioning for a price increase.

Key Price Levels:

Support: $204.12 (50-day SMA), $199.90 (Bollinger Band lower limit)

Resistance: $214.10 (recent high), $219.74 (Bollinger Band upper limit)

25-Day Price Forecast:

DHR is projected for $217.50 to $222.15 based on current trends, momentum, and indicators.

The projection is based on the current SMA trends, RSI momentum, MACD signals, and recent volatility (ATR). The 50-day SMA provides a base support level, while the recent highs and upper Bollinger Band offer resistance levels. The forecast range assumes a continuation of the current bullish trend.

Defined Risk Strategy Recommendations:

Based on the forecast of $217.50 to $222.15:

• Bull Call Spread: Buy DHR 261016C00210000 (strike $210.0, price $9.4) and sell DHR 261016C00222500 (strike $222.5, price $2.55). The net debit is $6.85, with a max profit of $5.65 and a breakeven at $216.85.
• Iron Condor: Sell DHR 261016P00205000 (strike $205.0, price $2.55) and DHR 261016C00215000 (strike $215.0, price $7.20), while buying DHR 261016P00207500 (strike $207.5, price $3.6) and DHR 261016C00217500 (strike $217.5, price $6.0). This strategy benefits from a range-bound market.

Risk Factors:

Technical Warning Signs: A drop below the 50-day SMA ($204.12) could indicate a trend reversal.

Sentiment Divergences: A sudden shift in sentiment could lead to rapid price movements.

Volatility and ATR: Increased volatility could impact the performance of defined risk strategies.

Summary & Conviction Level:

Overall Bias: Bullish

Conviction Level: High

One-line Trade Idea: Consider buying DHR with a defined risk strategy, targeting higher levels based on current trends and sentiment.